The Latin America, Middle East and Africa Neurostimulation Devices Market is expected to witness market growth of 13.5% CAGR during the forecast period (2020-2026).
Growth in the market for neurostimulation devices is due to increased use of neurostimulation devices in pain management and increased use of neurostimulation devices in developing economies. In addition, an increase in the incidence of chronic diseases is expected globally to boost the growth of the market for neurostimulation devices.
In addition, the increased demand for minimally invasive treatment, the uptake of technologically advanced products and the rise of aging demographics further accelerate market growth as they become more vulnerable to neurological diseases such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. The major barriers in the growth of the market for neurostimulation devices are adverse effects such as allergic reactions and tingling or prickling of the skin related to the implantation of the neurostimulation system into the body and higher product costs. The availability of other treatment options such as drug therapies and surgeries however restrict the market growth.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
By Applications
By Country
Companies Profiled
Unique Offerings from the Publisher
Growth in the market for neurostimulation devices is due to increased use of neurostimulation devices in pain management and increased use of neurostimulation devices in developing economies. In addition, an increase in the incidence of chronic diseases is expected globally to boost the growth of the market for neurostimulation devices.
In addition, the increased demand for minimally invasive treatment, the uptake of technologically advanced products and the rise of aging demographics further accelerate market growth as they become more vulnerable to neurological diseases such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. The major barriers in the growth of the market for neurostimulation devices are adverse effects such as allergic reactions and tingling or prickling of the skin related to the implantation of the neurostimulation system into the body and higher product costs. The availability of other treatment options such as drug therapies and surgeries however restrict the market growth.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators and
- Other Devices
By Applications
- Pain Management
- Hearing Loss
- Urinary Incontinence
- Parkinson's Disease
- Epilepsy and
- Other Applications
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corporation
- Medtronic PLC
- NeuroSigma, Inc.
- Integer Holdings Corporation
- LivaNova PLC
- NeuroPace, Inc.
- Neuronetics, Inc.
- Synapse BioMedical, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Neurostimulation Devices Market by Devices
Chapter 5. LAMEA Neurostimulation Devices Market by Applications
Chapter 6. LAMEA Neurostimulation Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corporation
- Medtronic PLC
- NeuroSigma, Inc.
- Integer Holdings Corporation
- LivaNova PLC
- NeuroPace, Inc.
- Neuronetics, Inc.
- Synapse BioMedical, Inc.
Methodology
LOADING...
